Objectives: To collect routine susceptibility data for coliforms isolated from patients with communityacquired urinary tract infections (UTIs) in Zenica-Doboj Canton, Bosnia and Herzegovina and to relate them to bacterial identification and patient demographics with a view to guiding empirical therapy.
Introduction
Increasing resistance to ampicillin and trimethoprim/sulfamethoxazole in Escherichia coli, the main causative pathogen of urinary tract infections (UTIs), has been demonstrated in urinary tract isolates obtained from patients visiting their general practitioners. [1] [2] [3] [4] [5] [6] Moreover, in the past few years, fluoroquinolones have been prescribed more frequently for the treatment of such infections. This has been followed by an increase in fluoroquinolone-resistant E. coli infections, which are difficult to treat. 1, 2, 7, 8 Many studies do not distinguish between community-acquired urinary isolates that were recovered from adult females (most of whom have uncomplicated UTIs) and those that have been recovered from children or men. 2, [9] [10] [11] In the present retrospective study, using the results of our routine diagnostic and susceptibility analyses, the aim was to investigate antimicrobial resistance and occurrence of the most common community-acquired UTI pathogens in Zenica-Doboj Canton during 1998-2001 in relation to age, gender and identified microorganisms and to propose appropriate empirical therapy.
Materials and methods
The Laboratory for Clinical and Sanitary Microbiology of the Cantonal Public Health Institution in Zenica covers a population of 331 229 in Zenica-Doboj Canton (112 471 males and 218 758 females). In 1998-2001, 54 638 consecutive urine samples were analysed, of which 6309 (11.5%) were positive. All urinary specimens with significant bacteriuria ( ‡10 5 cfu/mL of urine) were further processed. E. coli and other coliform microorganisms were identified according to standard biochemical tests, which identified most The disc diffusion method using Mueller-Hinton agar (Oxoid, Basingstoke, UK) was used to test 15 antimicrobials (Oxoid). The applied susceptibility criteria were in accordance with the NCCLS.
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E. coli control strain ATCC 25922 was used.
Name, surname, ID, address, date of birth and gender of the patient, date of isolation, specimen number, organism isolated and susceptibility results of positive UTI isolates were recorded as well as the number of urine specimens submitted during the study. The isolation of the same organism with the same susceptibility pattern from the same patient was considered as duplicate. Two sets of susceptibility rates were calculated: one including all coliform isolates and the other one excluding duplicate isolates. A few subsets in the group of non-duplicate coliform isolates were also calculated: E. coli/non-E. coli isolates, male/female and age groups (0-6, 7-14, 15-19, 20-64, >64 years).
The significance of differences in resistance according to subsets analysed was determined by means of the c 2 test for independence. A statistically significant difference was defined as a P value of <0.05, and a 95% confidence interval was used.
Results
Susceptibility results were obtained for 10 765 coliform UTI isolates; among them there were 5043 (46.8%) duplicate isolates and 5722 (53.2%) non-duplicate isolates. E. coli was isolated in 4245 (74.2%) non-duplicate urine samples, and non-E. coli were isolated in 1477 (25.8%) non-duplicate urine samples. Non-E. coli isolates identified in non-duplicate urine samples were Klebsiella spp. in 936 (16.4%), Proteus spp. in 422 (7.4%), Citrobacter spp. in 114 (2.0%) and Enterobacter spp. in 5 (0.1%). Table 1 shows that resistance rates were higher in duplicate isolates compared with non-duplicate isolates for all antibiotics tested except for ampicillin and chloramphenicol, and differences in the prevalence varied from 0.9% to 6.6%. However, statistically significant differences in susceptibility rates calculated with or without duplicate isolates were found for almost all antibiotics tested (P < 0.05), except for ampicillin, cefalotin, aztreonam and trimethoprim/sulfamethoxazole (P > 0.05). During the study period we found a significant increase in the prevalence of resistance against cefotaxime (P < 0.05) and all tested quinolones (P < 0.001); however, a decreasing trend was noted for trimethoprim/sulfamethoxazole (P < 0.001).
Male/female distribution of non-duplicate coliform UTI isolates was 16.0%/84.0%, respectively, resulting in incidence values of 1.6/5.2 per 1000 per year (mean values for 1998-2001) ( Table 2 ). Most isolates were obtained from patients over the age of 20 years, 81.9% for males and 72.9% for females. The lowest incidence of UTI coliform isolates of 1.1/1000/year was observed in the age group of 15-19 years, and the highest incidence of UTI coliform isolates was observed in the age group 0-6 years, 9.4/1000/year. Overall resistance rates for all antibiotics tested, except for imipenem, were significantly higher in the strains from the male population than from the female population (P < 0.001) (P > 0.05). Ampicillin and trimethoprim/ sulfamethoxazole displayed the highest resistance rates in both groups. E. coli/non-E. coli distributions were different in the strains from males versus females: 51.2%/48.8% and 78.6%/ 21.4%, respectively. E. coli was significantly (P < 0.001) more commonly isolated from female patients, and non-E. coli were isolated more commonly from male patients (P < 0.001). Further analyses of E. coli/non-E. coli distributions according to patient age have shown that E. coli was the most frequently isolated pathogen in all age groups of females: 83.1%, 88.3%, 74.2%, 75.2% and 79.9%, respectively (P < 0.05), compared with the frequency of isolation of non-E. coli isolates. However, the presence of non-E. coli isolates in male patients increased in proportion with increasing age: 28.6%, 48.9%, 40.0%, 48.7% and 65.2%, respectively. Therefore, E. coli was the more commonly isolated pathogen in the age group 0-6 years (P < 0.001) and non-E. coli were the more commonly isolated pathogens in the age group >64 years (P < 0.001) in male patients.
Inclusion of non-E. coli isolates (25.8%) in the analysis significantly (P < 0.001) influenced the resistance rates against all antibiotics except imipenem, in all subsets analysed. Klebsiella spp. showed the highest resistance rates for ampicillin, co-amoxiclav, cefuroxime, cefotaxime and aztreonam (82.9%, 67.9%, 34.5%, 
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29.7% and 20.6%, respectively), whereas Proteus spp. showed the highest resistance rates for gentamicin (44.5%). The highest resistance rate for cefalotin was noted in Citrobacter spp. isolates (72.9%). Inclusion of these organisms did not affect the core finding of antimicrobial resistance rate in both groups (Table 1) , but the values were much higher in males (Table 2) . Overall coliform antibiotic resistance rates for all antibiotics tested, except for imipenem and aztreonam, did not show a significant difference in relation to the age groups of patients in both males and females (P > 0.05) (P < 0.05). Ampicillin displayed exceptionally high resistance rates in all age groups of both male and female patients (up to 100.0% and 82.1%, respectively). Alarmingly high proportions of resistance to extended-spectrum b-lactam antibiotics were found in male patients. The highest resistance rates were found in the age group >64 years, reaching 60.6% and 53.1% for cefuroxime and cefotaxime, respectively (P < 0.001). Trimethoprim/sulfamethoxazole resistance rates were the lowest in the age group 20-64 years of female patients and in the age group 0-6 years of male patients (18.1% and 17.9%, respectively) (P < 0.001). The proportion of isolates resistant to gentamicin, chloramphenicol, all quinolones tested and nitrofurantoin increased with increasing age, in both male and female patients, and it was the highest in the age group >64 years (P < 0.001).
Discussion
The present study provides information about the antimicrobial susceptibility of community-acquired UTIs in relation to aetiological agents (E. coli/non-E. coli coliforms), gender and age. It has to be estimated that no selection was carried out prior to sending urine samples in our region, due to a high number of duplicate urine samples, 53.2%, and a low frequency of positive samples, 11.5%. In some other reports the number of positive urine samples reached 53.6%, and the number of duplicate samples reached only 14.3%. 9 Therefore, the antibiotic susceptibility data presented here probably reflect actual antibiotic resistance in practice, and hence should exclude the bias caused by use of strains isolated in the microbiology laboratory, which comprise mainly complicated 1 or pre-selected urine samples. 9 Indeed, some authors observed that when potential sampling biases were evaluated, no evidence was found that practices with high resistance rates were more selective in submitting urine samples to the laboratory. 10 However, presented data still have certain limitations that are inherent to all laboratory-based surveys, thus urine samples in the present study were probably not representative of UTI in practice and might influence the susceptibility data obtained, as previously stated. 14, 15 It is noteworthy that E. coli grew in 78.6% of the specimens from females, but in only 51.2.% of those from males. Corresponding rates for coliforms other than E. coli were 21.4% and 48.8%, respectively. Such a distribution of coliform communityacquired UTI pathogens was observed only in a few reports from the southern part of Europe, 2, 16 Latin America 7 and Britain, 17 but not in other countries. 2 According to a postulate stated previously, 18 the distribution of community-acquired UTI pathogens in this region with a significant proportion of non-E. coli coliforms (25.8%), namely Klebsiella spp. (14.9%), comprising the secondary pathogenic species, corresponded to that in hospital settings or complicated community UTIs. 1, 7, 19 The findings in the present study did not match with the study from Wales and Finland, where duplicate isolates had little influence on community or non-catheter outpatient specimens, 20 but significantly affected estimates of resistance rates for inpatients. 21 Given the above mentioned facts, it is evident that the number of complicated UTIs in this report was large.
Although this laboratory-based study did not provide the data about the presence and nature of symptoms and whether infection was complicated or not, the age, gender and microorganisms identified might provide necessary information needed for selection of empirical therapy. 14, 20 The relations of resistance rates for all antibiotics tested between E. coli and other coliforms were similar for male and female patients, but the values were much higher in males. It is a usual finding due to the different nature of UTI in males compared with females, although some different findings were also reported. 5, 7, 16, 20, 22, 23 These data illustrate several important points related to the drugs most frequently considered for empirical therapy for community-acquired UTIs. Despite the fact that no preselection of urine samples was made, ampicillin and co-trimoxazole resistance rates in the report were far higher in comparison with other reports. 5, 6, 17, 20, 23 As stated previously, the frequency of antimicrobial resistance in E. coli showed a geographical gradient, being greater in southern Europe, particularly in Spain and Portugal, than in northern Europe, 6, 20, 23, 24 thus, the results from our region could be compared with those from the above mentioned countries.
Empirical therapy with ampicillin in our region seems inadequate even for some usual population category, and should be avoided. In some regions co-trimoxazole also showed such high frequencies of resistance, 10 but in most European countries it is still useful.
2 Co-trimoxazole might be considered for empirical treatment of UTIs only in the age group 20-64 years of female patients and in the age group 0-6 years of male patients, in which resistance rates were low. Ciprofloxacin resistance in E. coli (4.4%) in our region still remained low 25 compared with some reports from Spain, where the resistance increased up to 20% and 36.0% in female and male patients, respectively. 1,2 But, our results suggest an alarmingly significant increase in the resistance to all quinolones (except to ofloxacin) in 2001 compared with 1998, an observation also reported by others. 5, 6, 23 Nitrofurantoin has shown a low overall coliform resistance rate in the age group 0-6 years of both male and female patients and should be considered as the first-line therapy. 26 Our results showed that it is highly recommended to perform urinalysis and antibiotic susceptibility testing in all patients, except in the age group 0-6 years of both male and female patients and in the age group 20-64 years of female patients, in which empirical therapy can be applied.
Due to the crisis in Bosnia and Herzegovina during the war period, and the lack of other antibiotics, ampicillin and cotrimoxazole were widely used. It is likely that an intensive usage of ampicillin and co-trimoxazole during the war period might have contributed to their high resistance rates, although the reports about relationship of high usage and resistance are controversial. [9] [10] [11] 16, 17, [27] [28] [29] [30] [31] A similar situation was reported in Serbia. 32 In poor and underdeveloped countries, where health organizations donate large amounts of antibiotics to treat many diseases, overall prevalence of antimicrobial resistance was notably high, reflecting irrational and inordinate use of antimicrobial agents. 4 In spite of the fact that the war finished by the end of 1995, a refugee camp still existed in Zenica-Doboj Canton until the end of 2001. This could also have influenced high ampicillin and co-trimoxazole resistance rates, because of increased prevalence of many diseases, person-to-person transmission of resistance plasmids or resistant strains in commensal faecal coliforms and crowding and poor sanitation. 10, 20, 28, [33] [34] [35] [36] The ease of procuring antibiotics without a prescription after the war in this region could have resulted in inordinate and irrational use of antibiotics. Consequently, ampicillin and co-trimoxazole were probably replaced by fluoroquinolones in the treatment of infectious diseases. As the decay in the prevalence of drug-resistant bacteria occurs slowly after reduction in consumption, 9 this could explain a decrease in ampicillin and cotrimoxazole resistance and an increase in fluoroquinolone resistance after the war period in the present study. Some authors have stated that quinolone resistance is higher in developing countries than in developed nations because of the use of less active quinolones, such as nalidixic acid, and/or the use of low dosages of more potent compounds such as ciprofloxacin resulting in selection of mutant isolates. 8 Although the current study addresses a local problem in Bosnia and Herzegovina, where a higher prevalence of antibiotic resistance compared with other countries appeared, many other poor and developing countries are faced with a similar situation. 4, 32 The reason for high prevalence of resistance is not only limited to the level of prescribing and usage, 11, 20, [29] [30] [31] but is likely to be complex with respect to the age profile of the population, social deprivation, locality and the use of antibiotics in veterinary and agricultural practice. 4, 26, 37, 38 To optimize the use of empirical antibacterial therapy for UTI, physicians should know the aetiology and susceptibility patterns of UTI pathogens in their population. Changes in rates of resistance have been observed to follow changes in prescribing of the drugs.
